We show that antigen-specific CD8+ cells bearing an exhaustion-related gene signature from mice as well as human TIL express robust levels of Fgl2, and this expression in melanoma patients is correlated with decreased patient survival during checkpoint inhibition. This evidence concerns the gene CD8A and melanoma.